Filtered By:
Drug: Medroxyprogesterone
Countries: UK Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 4 results found since Jan 2013.
Association between Menopausal Hormone Therapy and Incidence of Psoriasis: A Secondary Analysis from the Women's Health Initiative Randomized Clinical Trials
Br J Dermatol. 2021 Apr 29. doi: 10.1111/bjd.20410. Online ahead of print.ABSTRACTEstrogen level fluctuations have been linked to psoriasis (1); however, the association between menopausal hormone therapy and risk of psoriasis is largely unexplored. We analyzed data from the Women's Health Initiative's (WHI) randomized controlled trials comparing conjugated equine estrogens (CEE) vs. placebo and CEE plus medroxyprogesterone acetate (MPA) vs. placebo to investigate the association between hormone therapy use and psoriasis.PMID:33913153 | DOI:10.1111/bjd.20410
Source: The British Journal of Dermatology - April 29, 2021 Category: Dermatology Authors: A A Chan J Noguti C T Yang S R Feldman R B Wallace A H Shadyab J E Manson A K Aragaki R T Chlebowski D J Lee Source Type: research
